Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: Implications for clinical trials

Vincent Lambert, Carine Munaut, Peter Carmeliet, Robert D. Gerard, Paul J. Declerck, Ann Gils, Carel Claes, Jean Michel Foidart, Agnès Noël, Jean Marie Rakic

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: Implications for clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences